*** tracy always involved when working with anesthesia
Specifications, script and data collection tool for eMAR usability testing
given to scheduled end users in advance of testing
one usability testing questionnaire
per end user
one patient unique to each end user
, with appropriate medications “available” to administer for each scenario
installed, including voice recording device
access to appropriate test version of EHR
Laptop in EHR, recording software “set to roll” with audio recording device (recording software
to record audio and screen navigation
Usability Testing Questionnaire to be completed at end of testing
Data collection sheets and instructions (following)
Thank you for being willing to participate in this usability testing. This is part of a joint effort between Geisinger and the University of Wisconsin-Madison to assess the proposed design of the eMAR (electronic medication administration record) to be used by staff nurses. What we ask you to do today will provide us true USER insight regarding the work thus far. By no means are we judging your performance, but rather how well the eMAR is designed to meet user expectations and needs based on your current practice and use of the paper MAR. I will guide you through the eMAR to a point where I will then ask you to complete various tasks – 3 scenarios in total. I will explain the objective of each scenario as we begin it. Throughout this testing I ask you to “think aloud” as you use the eMAR. By this I mean that you convey to me verbally whatever is on your mind. I may at times ask questions or remind you to do this. DO NOT worry if you get “stuck” as we realize the eMAR warrants improvement. If this occurs I will help you proceed with the respective scenario. Your feedback will provide us valuable information to make necessary changes to the design of the eMAR. Do you have any questions before we begin?
As a matter of clarification it may be helpful for you to know that the eMAR has been designed to replicate the way we understand nurses currently
use the paper MAR. In addition we also hope features related to standardization of clinical practice will increase efficiency for nurses while also
meeting regulatory requirements .
Here we go…………. To access the EHR please do the following:
_____ for User ID
xxx for password
yyy for department
You are now at the “Inpatient Home, Patient Lists” screen…. Select ________by single-clicking on the name. Now proceed to the toolbar
immediately below the list of ICU patients and click on the last icon on the toolbar labeled “Due Meds”. Now go to the lower half of the screen to
view details regarding the patient. Click on the down arrow in the right hand scroll bar until the shaded blue header line containing the label “due
medications” appears. Single click on “[ Open MAR]” – on the far right side of the shaded header – to proceed.
You may now notice that there are tabs above the medication list that refer to the nature of the medication order (e.g., scheduled, continuous, PRN,
etc). Above the tabs are fields that display the current status of your work day – the shift and date. Finally, the columns associated with the
medication list display the times corresponding to each hour of this shift. The current hour is highlighted bright green.
In this scenario we will ask you to document medications you just administered, including one that requires dual sign-off, and one (Colace) that was
not administered because it was contraindicated ……
AS A REMINDER, PLEASE “THINK ALOUD” TO THE BEST OF YOUR ABILITY AS YOU PROGRESS THROUGH THE eMAR.
It is currently ______ o’clock and you need to document administration of the medications you just gave your patient.
Looking at the medication list, please click on the top of the column that coincides with the current time(highlighted in bright green). You
now see the full list of medications due.
1) Please document administration of all of the meds.
2) Include the fact that Colace was not administered due to the patient experiencing severe diarrhea.
3) When you incur Cefazolin, that requires dual signoff, tell us how you would proceed.
Reaction to dual
Able to document
all other meds
In this second scenario we ask that you document administration of a medication due to be administered on another shift. In other words, an overdue
med. Prilosec, ordered to be given to your patient once daily at 6:00 a.m. was missed. Please document the Prilosec you just now administered.
Able to correctly
Able to correctly
based on its
need to select
Able to select
current time (Y/N)
Next we will ask you to document an injectable drug.
Please now document administration of a PRN injectable drug – Phenergan – that you injected in the patient’s buttocks.
Able to correctly
need to go
to PRN tab
Thank you. You have now completed the scenarios.
I now have three questions for you that concern a design issue we presently face. We are trying to determine the best, most consistent
documenting blood product administration in EHR. If you were a Geisinger designer of EHR, in what activities (e.g., eMAR, flowsheets, notes,
blood bank documentation, etc.) would you assign documentation by nursing of…. ALBUMIN & why?
PACKED RED BLOOD CELLS and why?
HESPAN and why?
Based on the experience you just had, we ask you to complete this questionnaire. There are no “right” answers. We only ask that you convey your perceptions to the eMAR that you just worked with. THANK YOU!!!
Beter effect antidepressiva Suppletie foliumzuur bij gebruik fluoxetine door Ary van der Kuy, Lan Kiauw de Munck-Khoe - 05-10-2012 Foliumzuur verbetert vaak de respons op fluoxetine en andere antidepressiva bij therapieresistente patiënten. Foliumzuur is nodig voor de synthese van monoamine-neurotransmitters. • Casus Een 54-jarige man met de diagnose ernstige depressie, zonder p
Kahn test see SYPHILIS SERODIAGNOSIS Kairomones see PHEROMONES Kallikrein hK3 see PROSTATE-SPECIFIC ANTIGEN Kampo medicine see MEDICINE, KAMPO Kanner's syndrome see AUTISTIC DISORDER Kanpo medicine see MEDICINE, KAMPO Karate see MARTIAL ARTS Katz adjustment scales see PSYCHIATRIC STATUS RATING SCALES Keratinomyces see ARTHODERMATACEAE KERATITI